Healthy Clinical Trial
Official title:
Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array
The purpose of this study is to assess the immunological status of patients using Premarin. Premarin use is associated with an enhanced immune status, and possibly even some anti-cancer effect. The researchers will compare the use of Premarin with those not using hormone replacement therapy (HRT) to track the effects of Premarin in reducing the risk of infection and swelling.
In recent times, adverse publicity has affected the sales of hormone replacement therapies
and the perception of women as to whether or not HRTs should be taken. While a number of
brands are available, those from Wyeth are the market leaders. Previous studies by our group
have shown an advantage of Premarin, a natural conjugated equine estrogen, in fostering
recovery of the Lactobacillus flora in the vagina. These organisms have been shown to help
protect the host from urinary and vaginal infections. In the present proposal, we aim to
further examine the beneficial effects of Premarin through the use of a human genome array
technology.
New microarrays allow measurements to be made of 38,000 or more gene expressions on a single
sample. We have recently used an Affymetrix array to examine up and down regulation of
vaginal genes from a healthy premenopausal woman before and after administration of a
probiotic. Somewhat to our surprise, we noted that over 9,000 genes were expressed and major
down regulation occurred in cancer and other genes such as inflammatory cytokines. This was
especially interesting as it showed that vaginal treatment could influence genes associated
with, for example, the intestine. The array provided data or relevance to estrogen
replacement therapy, namely the ability to detect and examine changes in estrogen associated
factors.
In short, this system can examine changes to inflammation and host defenses. Based upon the
findings of Raz and others (1993), it is likely that Premarin down regulates inflammation,
either directly or via an alteration of the vaginal environment resulting in restoration of
lactobacilli. Another benefit of the restoration of lactobacilli is that these organisms
have anti-cancer properties.
The increased prevalence after menopause of urogenital (bladder and vaginal) infections and
complications can be counteracted to some extent by restoration of the normal vaginal
microbiota. These infections are extremely common, and treatment with antibiotics and
antifungals is compromised by rapid rises in drug resistance (up to 30% for fluoroquinolones
in some countries and a doubling of resistance to trimethoprim-sulfamethoxazole). BV has
been associated with increased risk of preterm labour (McGregor et al. 1993; Hay et al.
1994; Chaim et al. 1997) and sexually transmitted diseases including HIV, herpes simplex
virus, gonorrhea and Chlamydia (Sewankambo et al. 1997; Taha et al. 1998; Olinger et al.
1999; Wiesenfeld et al. 2003; Cherpes et al. 2003). Notably, 35-50% of patients and around
50% of UTI patients suffer a recurrence of infection within 3 months. Post-menopausal women
have low levels of lactobacilli and high numbers of pathogens, while 100% of those receiving
Premarin are colonized by lactobacilli (Burton et al. 2003; Devillard et al. 2004; Heinemann
& Reid, 2005).
;
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |